LeonaBio Inc
LONA
53 hedge funds and large institutions have $5M invested in LeonaBio Inc in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 4 closing their positions.
300% more call options, than puts
Call options by funds: $4K | Put options by funds: $1K
0.14% less ownership
Funds ownership: 4.64% → 4.5% (-0.14%)
5% less funds holding
Funds holding: 56 → 53 (-3)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
52% less capital invested
Capital invested by funds: $10.5M → $5M (-$5.51M)
63% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$188K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$22K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$12.6K |
| 4 |
IF
Integrity Financial
Cheyenne,
Wyoming
|
+$8.91K |
| 5 |
Renaissance Technologies
New York
|
+$5.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$92.3K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$74.8K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$57.1K |
| 4 |
Two Sigma Advisers
New York
|
-$42.6K |
| 5 |
BA
Bristlecone Advisors
Bellevue,
Washington
|
-$37.8K |
LONA Hedge Fund Activity: Q1 2025 in Review
53 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q1 2025, worth a combined $5M — down 52% from $10.5M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of LONA and 2 opened new positions — a net loss of 2 holders — while 19 trimmed existing stakes and 7 added.
The largest buyer was BML Capital Management, adding an estimated $188K. The largest seller was GSA Capital Partners, cutting an estimated $92.3K.
- 53 institutional investors held LeonaBio Inc (LONA) as of Q1 2025, down from 56 in Q4 2024.
- Funds reported $5M of LeonaBio Inc stock for Q1 2025, down 52% quarter-over-quarter.
- 2 funds opened new LeonaBio Inc positions in Q1 2025 and 4 closed out, a net change of -2 holders.
- The largest LeonaBio Inc buyer in Q1 2025 was BML Capital Management, an estimated $188K added.
- The largest LeonaBio Inc seller in Q1 2025 was GSA Capital Partners, an estimated $92.3K sold.
Based on aggregated 13F filings for Q1 2025.